Novel protein transduction domain mimics as nonviral delivery vectors for sirna targeting NOTCH1 in primary human T cells

Molecular Therapy

Volumn 21, Issue 1, 2013, Pages 201-209

  Tezgel, A Özgül ^a   Gonzalez Perez, Gabriela ^a   Telfer, Janice C ^a   Osborne, Barbara A ^a   Minter, Lisa M ^a   Tew, Gregory N ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; PEPTIDE; PROTEIN TRANSDUCTION DOMAIN MIMIC 1; PROTEIN TRANSDUCTION DOMAIN MIMIC 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ASSAY; CONTROLLED STUDY; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; PROTEIN TARGETING; PROTEIN TRANSPORT; TH1 CELL; WESTERN BLOTTING;

EID: 84871920964     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.209     Document Type: Article

References (29)

1. de Fougerolles, A, Vornlocher, HP, Maraganore, J and Lieberman, J (2007). Interferingwith disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6:443-453. (Pubitemid 47064567)
2. Kim, DH and Rossi, JJ (2007). Strategies for silencing human disease using RNAinterference. Nat Rev Genet 8: 173-184.
3. Whitehead, KA, Langer, R and Anderson, DG (2009). Knocking down barriers:advances in siRNA delivery. Nat Rev Drug Discov 8: 129-138.
4. Goffinet, C and Keppler, OT (2006). Efficient nonviral gene delivery into primarylymphocytes from rats and mice. FASEB J 20: 500-502. (Pubitemid 46671229)
5. Marodon, G, Mouly, E, Blair, EJ, Frisen, C, Lemoine, FM and Klatzmann, D(2003). Specific transgene expression in human and mouse CD4+ cells usinglentiviral vectors with regulatory sequences from the CD4 gene. Blood 101:3416-3423. (Pubitemid 36857923)
6. Zhang, Y, Lu, H, LiWang, P, Sili, U and Templeton, NS (2003).Optimization of gene expression in nonactivated circulating lymphocytes. MolTher 8: 629-636. (Pubitemid 37321692)
7. Jantsch, J, Turza, N, Volke, M, Eckardt, KU, Hensel, M, Steinkasserer, A et al. (2008).Small interfering RNA (siRNA) delivery into murine bone marrow-derived dendriticcells by electroporation. J Immunol Methods 337: 71-77.
8. Brahmamdam, P, Watanabe, E, Unsinger, J, Chang, KC, Schierding, W, Hoekzema, AS etal. (2009). Targeted delivery of siRNA to cell death proteins in sepsis. Shock 32: 131-139.
9. Liu, Z, Winters, M, Holodniy, M and Dai, H (2007). siRNA delivery into human T cellsand primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl 46:2023-2027. (Pubitemid 46973660)
10. Marshall, NB, Oda, SK, London, CA, Moulton, HM, Iversen, PL, Kerkvliet, NI etal. (2007). Arginine-rich cell-penetrating peptides facilitate delivery of antisenseoligomers into murine leukocytes and alter pre-mRNA splicing. J Immunol Methods325: 114-126. (Pubitemid 47238294)
11. Eguchi, A, Meade, BR, Chang, YC, Fredrickson, CT, Willert, K, Puri, N et al. (2009).Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNAbinding domain fusion protein. Nat Biotechnol 27: 567-571.
12. Trabulo, S, Cardoso, AL and Mano-Pedroso de Lima, MC (2010). Cell-penetratingpeptides-mechanisms of cellular uptake and generation of delivery systems.Pharmaceuticals 3: 961-993.
13. Fonseca, SB, Pereira, MP and Kelley, SO (2009). Recent advances in the use of cellpenetratingpeptides for medical and biological applications. Adv Drug Deliv Rev 61:953-964.
14. Endoh, T and Ohtsuki, T (2009). Cellular siRNA delivery using cell-penetratingpeptides modified for endosomal escape. Adv Drug Deliv Rev 61: 704-709.
15. Eguchi, A and Dowdy, SF (2009). siRNA delivery using peptide transduction domains.Trends Pharmacol Sci 30: 341-345.
16. Crombez, L, Charnet, A, Morris, MC, Aldrian-Herrada, G, Heitz, F and Divita, G(2007). A non-covalent peptide-based strategy for siRNA delivery. Biochem Soc Trans35(Pt 1): 44-46.
17. Crombez, L, Aldrian-Herrada, G, Konate, K, Nguyen, QN, McMaster, GK, Brasseur, Ret al. (2009). A new potent secondary amphipathic cell-penetrating peptide for siRNAdelivery into mammalian cells. Mol Ther 17: 95-103.
18. Morris, MC, Gros, E, Aldrian-Herrada, G, Choob, M, Archdeacon, J, Heitz, F et al.(2007). A non-covalent peptide-based carrier for in vivo delivery of DNA mimics.Nucleic Acids Res 35: e49.
19. Richard, JP, Melikov, K, Vives, E, Ramos, C, Verbeure, B, Gait, MJ et al. (2003). Cellpenetratingpeptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem278: 585-590. (Pubitemid 36043612)
20. Artavanis-Tsakonas, S, Rand, MD and Lake, RJ (1999). Notch signaling: cell fatecontrol and signal integration in development. Science 284: 770-776. (Pubitemid 29291335)
21. Osborne, BA and Minter, LM (2007). Notch signalling during peripheral T-cellactivation and differentiation. Nat Rev Immunol 7: 64-75. (Pubitemid 46020828)
22. McNaughton, BR, Cronican, JJ, Thompson, DB and Liu, DR (2009). Mammalian cellpenetration, siRNA transfection, and DNA transfection by supercharged proteins. ProcNatl Acad Sci USA 106: 6111-6116.
23. Mantei, A, Rutz, S, Janke, M, Kirchhoff, D, Jung, U, Patzel, V et al. (2008). siRNAstabilization prolongs gene knockdown in primary T lymphocytes. Eur J Immunol 38:2616-2625.
24. Minter, LM, Turley, DM, Das, P, Shin, HM, Joshi, I, Lawlor, RG et al. (2005). Inhibitorsof gamma-secretase block in vivo and in vitro T helper type 1 polarization bypreventing Notch upregulation of Tbx21. Nat Immunol 6: 680-688. (Pubitemid 41716741)
25. Chan, SM, Olson, JA and Utz, PJ (2005). Single-cell analysis of siRNA-mediatedgene silencing using multiparameter flow cytometry. Cytometry Part A 69A:59-65.
26. Kim, WJ, Christensen, LV, Jo, S, Yockman, JW, Jeong, JH, Kim, YH et al. (2006).Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNAeffectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 14:343-350. (Pubitemid 44184964)
27. Lee, YK, Kim, KS, Kim, JS, Baek, JE, Park, SI, Jeong, HY et al. (2010). Leukemia-specificsiRNA delivery by immunonanoplexes consisting of anti-JL1 minibody conjugated tooligo-9 Arg-peptides. Mol Cells 29: 457-462.
28. Som, A, Reuter, A, Tew, GN (2012). Protein transduction domain mimics: the role ofaromatic functionality. Angew Chem Int Ed 51: 980-983.
29. Som, A, Tezqel, AO, Gabriel, GJ, Tew, GN (2011). Self activation indenovo designed mimics of cell-penetrating peptides. Angew Chem Int Ed 50:6147-6150.